Skip to main content
. 2020 Oct 12;10(10):1436. doi: 10.3390/biom10101436
AID Autoimmune diseases
ANA Antinuclear antibody
Anti-CCP Anti-cyclic citrullinated peptide
ASIA Autoimmune/Inflammatory syndrome induced by adjuvants
ASMA Anti-smooth muscle antibody
CI Confidence interval
CPI Check-point inhibitors
CTLA Cytotoxic T lymphocyte antigen
ENA Extractable nuclear antigens
HBV Hepatitis B virus
HLA Human leukocyte antigen
ICIs Immune checkpoint inhibitors
IFN-γ Interferon gamma
IL Interleukin
irAEs Immune-related adverse events
NZB New Zealand black
NZM New Zealand mixed
OR Odds ratio
PD-1 Programmed cell death receptor-1
PFS Progression free survival
RF Rheumatoid factor
SADs Systemic autoimmune diseases
SBIs Silicone breast implants
SFN Small fiber neuropathy
SIIS Silicone implant incompatibility syndrome
SS Sjogren’s syndrome
SSc Systemic sclerosis
TGF-β Transforming growth factor β
Th T helper lymphocytes
TLR-4 Toll-like receptor 4
TNF-α Tumor necrosis factor α
UCTD Undifferentiated connective tissue disease